Dr. Volker Patzel, chemist, received in 1998 his Ph.D. from the Ruprecht-Karls-University in Heidelberg and in 2002 his MBA from the Steinbeis University in Berlin. Worked until 2000 as a postdoc at the German Cancer Research Centre in Heidelberg and then till 2009 as research group leader at the Max Planck Institute for Infection Biology in Berlin. Since 2009 he holds a dual appointment as Asst. Professor at the National University of Singapore and Asst. Director of Research at the University of Cambridge. Since 2004, founder and director of the Steinbeis Transfer Centre for Nucleic Acids Design Dr. Volker Patzel, chemist, received in 1998 his Ph.D. from the Ruprecht-Karls-University in Heidelberg and in 2002 his MBA from the Steinbeis University in Berlin. Worked until 2000 as a postdoc at the German Cancer Research Centre in Heidelberg and then till 2009 as research group leader at the Max Planck Institute for Infection Biology in Berlin. Since 2009 he holds a dual appointment as Asst. Professor at the National University of Singapore and Asst. Director of Research at the University of Cambridge. Since 2004, founder and director of the Steinbeis Transfer Centre for Nucleic Acids Design

Design and delivery of ribonucleic acids for enhancement, inhibition or repair of gene expression towards diagnosis and treatment of human diseases. Targets are viral pathogens such as HIV-1, HPV-16, and HBV as well as cancer.